GLUCANTIME 1.5 g/5 ml, solution for injection 5 ampoules of 5 ml
Active ingredients: Antimony, Meglumine antimoniate
Commercialized according to BDPM
Solution for injection5 ampoules of 5 mlintramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- GLUCANTIME 1,5 g/5 ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire
- Presentation description
- 5 ampoule(s) en verre de 5 ml
- Marketing authorisation holder
- SANOFI WINTHROP INDUSTRIE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Sept 1986
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60576634CIP73272667CIP133400932726677Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ANTIMONIATE DE MÉGLUMINEsolution | 1,500 g · une ampoule de 5 ml | SA |
| ANTIMOINEsolution | 0,4050 g · une ampoule de 5 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.